Principia Biopharma Inc. Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Principia Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Principia Biopharma Inc. for December 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2019 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Sell | S | 60.00 | 495 | 29,700 | 494 | 989 to 494 (-50.05 %) |
| Dec 20 2019 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Sell | S | 60.00 | 495 | 29,700 | 494 | 989 to 494 (-50.05 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 54.28 | 1,295 | 70,292 | 15,696 | 17 K to 15.7 K (-7.62 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 53.69 | 2,205 | 118,392 | 16,991 | 19.2 K to 17 K (-11.49 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 54.28 | 1,295 | 70,292 | 15,696 | 17 K to 15.7 K (-7.62 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 52.77 | 1,000 | 52,775 | 19,196 | 20.2 K to 19.2 K (-4.95 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 53.69 | 2,205 | 118,392 | 16,991 | 19.2 K to 17 K (-11.49 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 54.36 | 1,014 | 55,116 | 54,179 | 55.2 K to 54.2 K (-1.84 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 52.77 | 1,000 | 52,775 | 19,196 | 20.2 K to 19.2 K (-4.95 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 53.94 | 6,661 | 359,314 | 55,193 | 61.9 K to 55.2 K (-10.77 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 54.36 | 1,014 | 55,116 | 54,179 | 55.2 K to 54.2 K (-1.84 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 52.86 | 11,485 | 607,064 | 61,854 | 73.3 K to 61.9 K (-15.66 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 53.94 | 6,661 | 359,314 | 55,193 | 61.9 K to 55.2 K (-10.77 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 51.80 | 5,840 | 302,502 | 73,339 | 79.2 K to 73.3 K (-7.38 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 52.86 | 11,485 | 607,064 | 61,854 | 73.3 K to 61.9 K (-15.66 %) |
| Dec 19 2019 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 51.80 | 5,840 | 302,502 | 73,339 | 79.2 K to 73.3 K (-7.38 %) |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | M | 4.54 | 5,505 | 25,004 | 24,551 | |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 49.87 | 1,300 | 64,825 | 35,609 | 36.9 K to 35.6 K (-3.52 %) |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 49.29 | 4,205 | 207,266 | 36,909 | 41.1 K to 36.9 K (-10.23 %) |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Buy | M | 4.54 | 5,505 | 25,004 | 41,114 | 35.6 K to 41.1 K (+15.46 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 5.00 | 4,129 | 20,629 | 0 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 5.00 | 4,129 | 20,629 | 0 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 871 | 4,114 | 12,758 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 871 | 4,114 | 12,758 | |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.83 | 1,619 | 80,682 | 120,143 | 121.8 K to 120.1 K (-1.33 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.83 | 1,619 | 80,682 | 120,143 | 121.8 K to 120.1 K (-1.33 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.20 | 3,381 | 166,352 | 121,762 | 125.1 K to 121.8 K (-2.70 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.20 | 3,381 | 166,352 | 121,762 | 125.1 K to 121.8 K (-2.70 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 5.00 | 4,129 | 20,629 | 125,143 | 121 K to 125.1 K (+3.41 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 5.00 | 4,129 | 20,629 | 125,143 | 121 K to 125.1 K (+3.41 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 871 | 4,114 | 121,014 | 120.1 K to 121 K (+0.72 %) |
| Dec 13 2019 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 871 | 4,114 | 121,014 | 120.1 K to 121 K (+0.72 %) |